By Jeff Overley ( March 20, 2013, 6:58 PM EDT) -- Sen. Ron Wyden, D-Ore., on Tuesday urged the National Institutes of Health to study whether drugmakers are benefiting excessively from public-private partnerships aimed at developing new medicines, prompting a furious pushback from Pfizer Inc., whose newly approved rheumatoid arthritis treatment got a lift from taxpayer-funded research....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.